Scholar Rock
SRRK • NASDAQ
Scholar Rock is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David L. Hallal, with a market cap of $4.9B.
CEODavid L. Hallal
Next Earnings
Upcoming earnings announcement for Scholar Rock
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.82
Revenue Estimate
$4.0M
Earnings History
Past 12 earnings reports for Scholar Rock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.88Est: -$0.87 | -1.1% | -Est: $2.3M | -100.0% |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.90Est: -$0.85 | -5.9% | -Est: $50.0K | -100.0% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.98Est: -$0.66 | -48.5% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.67Est: -$0.71 | +5.6% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.61Est: -$0.63 | +3.2% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.66Est: -$0.60 | -10.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.60Est: -$0.61 | +1.6% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.59Est: -$0.48 | -22.9% | - | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | -$0.50Est: -$0.49 | -2.0% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.53Est: -$0.52 | -1.9% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.47Est: -$0.55 | +14.5% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.49Est: -$0.58 | +15.5% | - | — | — |